KEY
51
-3
BSX
68
-3
VFC
27
5
CHK
31
7
SWN
52
3
FTI
87
-4
SYY
54
-2
T
50
2
ALL
51
-5
AVGO
54
2
A
55
-3
MDLZ
55
2
PAYX
59
2
EMC
85
8
AMGN
55
-2
MNST
65
3
ZION
55
-4
HPE
29
4
BBY
52
3
DHR
51
-3
KEY
51
-3
BSX
68
-3
VFC
27
5
CHK
31
7
SWN
52
3
FTI
87
-4
SYY
54
-2
T
50
2
ALL
51
-5
AVGO
54
2
A
55
-3
MDLZ
55
2
PAYX
59
2
EMC
85
8
AMGN
55
-2
MNST
65
3
ZION
55
-4
HPE
29
4
BBY
52
3
DHR
51
-3
Financhill
Back

Altimmune Stock Predictions

The little-known AI stock you need to read about now...

Get the name - FREE.
Buy
61

ALT
Altimmune

Last Price:
7.83
Seasonality Move:
26.83%

7 Day Trial

ALL ACCESS PASS

$ 7

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 3.4% based on the past 18 years of stock performance.
  • Altimmune has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $7.37. The Score for ALT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 3.4% based on the past 18 years of stock performance.

Altimmune Stock Rating

Buy
61
Altimmune (ALT) is a Buy

Is Altimmune overpriced?

  • Altimmune has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%

Altimmune Stock Price History

Is ALT stock going to rise?

  • The current trend is relatively stagnant and ALT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
2.09

Prediction Charts

Market Cap:
522.5M
Price in USD:
7.37
Volume:
2.14M
Beta:
1.16

Technical Analysis

SMA50:
8.53
SMA100:
9.38
SMA200:
6.23
52-Wk Change:
44.79%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 7.37 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 7.55 7.08 7.75 6.98
Apr-25 6.88 7.20 7.25 6.78
Apr-26 7.18 7.26 7.42 6.90
Apr-29 6.86 6.40 6.89 6.28
Apr-30 6.35 6.55 6.73 6.31
May-1 6.64 7.07 7.39 6.55
May-2 7.18 7.19 7.35 6.81
May-3 7.41 7.30 7.63 7.19
May-6 7.38 7.36 7.51 7.25
May-7 7.40 7.28 7.40 7.05
May-8 7.04 7.16 7.55 6.81
May-9 7.22 7.72 8.08 7.17
May-10 7.65 7.22 7.81 7.06
May-13 7.32 7.37 7.57 7.12

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.56 per share, an increase this year of $0.61 per share, and a decrease next year of $0.75 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.